173 related articles for article (PubMed ID: 21275944)
1. Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia.
Pelletier F; Parratte B; Penz S; Moreno JP; Aubin F; Humbert P
Br J Dermatol; 2011 Mar; 164(3):617-22. PubMed ID: 21275944
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of vulvodynia with botulinum toxin A.
Tieu KD; MacGregor JL
Arch Dermatol; 2011 Feb; 147(2):251-2. PubMed ID: 21339463
[No Abstract] [Full Text] [Related]
3. Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study.
Petersen CD; Giraldi A; Lundvall L; Kristensen E
J Sex Med; 2009 Sep; 6(9):2523-37. PubMed ID: 19619148
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin-treatment of localized provoked vulvodynia refractory to conventional treatment.
Hedebo Hansen T; Guldberg R; Meinert M
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():6-9. PubMed ID: 30639955
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
[TBL] [Abstract][Full Text] [Related]
6. Long-term assessment of effectiveness and quality of life of OnabotulinumtoxinA injections in provoked vestibulodynia.
Pelletier F; Girardin M; Humbert P; Puyraveau M; Aubin F; Parratte B
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):106-11. PubMed ID: 26491951
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin A as a Treatment for Provoked Vestibulodynia: A Randomized Controlled Trial.
Haraldson P; Mühlrad H; Heddini U; Nilsson K; Bohm-Starke N
Obstet Gynecol; 2020 Sep; 136(3):524-532. PubMed ID: 32769643
[TBL] [Abstract][Full Text] [Related]
8. Vestibulodynia: Clinical characteristics, first-line treatments, and factors associated with escalation of treatment with EMG-guided injections of botulinum toxin in a retrospective french cohort study.
Neuville C; Parratte B; Lombion S; Aubin F; Gallais Sérézal I; Pelletier F
Ann Dermatol Venereol; 2024 Jun; 151(2):103277. PubMed ID: 38678773
[TBL] [Abstract][Full Text] [Related]
9. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis.
Diomande I; Gabriel N; Kashiwagi M; Ghisu GP; Welter J; Fink D; Fehr MK; Betschart C
Arch Gynecol Obstet; 2019 Apr; 299(4):993-1000. PubMed ID: 30707361
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review.
Kharkar S; Ambady P; Venkatesh Y; Schwartzman RJ
Pain Physician; 2011; 14(5):419-24. PubMed ID: 21927045
[TBL] [Abstract][Full Text] [Related]
13. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
Mouttalib S; Khan S; Castel-Lacanal E; Guillotreau J; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
BJU Int; 2010 Dec; 106(11):1677-80. PubMed ID: 20590550
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study.
Dykstra DD; Presthus J
J Reprod Med; 2006 Jun; 51(6):467-70. PubMed ID: 16846084
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin injection of the subscapularis muscle.
Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
O'Leary M; Dierich M
Urol Nurs; 2010; 30(4):228-34. PubMed ID: 20949807
[TBL] [Abstract][Full Text] [Related]
18. The effect on quality of life of long-term botulinum toxin A injections to maintain ocular alignment in adult patients with strabismus.
Hancox J; Sharma S; MacKenzie K; Adams G
Br J Ophthalmol; 2012 Jun; 96(6):838-40. PubMed ID: 22368263
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A for neuropathic itch.
Wallengren J; Bartosik J
Br J Dermatol; 2010 Aug; 163(2):424-6. PubMed ID: 20346021
[No Abstract] [Full Text] [Related]
20. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
Beer KR; Wilson F
Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
[No Abstract] [Full Text] [Related]
[Next] [New Search]
